Skip to Content

Rotech waits for ‘market changes’

Rotech waits for ‘market changes’

WASHINGTON – Rotech Healthcare has paused its plans to go public. 

The company filed for an initial public offering* of up to $100 million in July 2021, with plans to list on the Nasdaq under the symbol ROTK. 

“(We’re) just timed out for now,” said President and CEO Tim Pigg in an email to HME News. “We have not updated but do plan to continue to update once the market changes.” 

Rotech’s filing was declared abandoned on Aug. 3, according to the U.S. Securities and Exchange Commission. 

When it becomes public, Rotech will join a few other larger HME providers on the Nasdaq, including AdaptHealth and Apria Healthcare (now part of Owens & Minor). 

Rotech says it offers a comprehensive range of home medical equipment and products and services across five core business lines: oxygen, ventilators, sleep therapy, wound care and DME. Its payer mix includes commercial insurers, Medicare, Medicaid, the VA and private individuals. 

As of March 31, 2021, the company says it served more than 600,000 active patients across more than 300 service locations in 45 states. 


To comment on this post, please log in to your account or set up an account now.